Zhejiang Provincial People's Hospital
Clinical trials sponsored by Zhejiang Provincial People's Hospital, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New drug cocktail aims to tame stubborn arthritis Results expected Mar 2027 (estimated)
- Can engineered red blood cells fight cancer? new trial launches Results expected Apr 2027 (estimated)
- Herbal pills tested as possible treatment for thyroid nodules Results expected Jun 2027 (estimated)
-
New drug cocktail aims to shrink head and neck tumors before surgery
Disease control By invitation onlyThis phase 2 trial is testing whether combining two drugs, pertuzumab and lenvatinib, can shrink tumors before surgery in people with advanced head and neck cancer. About 30 participants will receive 2-4 cycles of the drug combination, then undergo surgery. The main goal is to se…
Phase 2 • Sponsor: Zhejiang Provincial People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can a smaller dose of a white blood cell booster protect cancer patients just as well?
Prevention By invitation onlyResearchers are studying whether a lower 3mg dose of pegylated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) can prevent febrile neutropenia, a serious drop in infection-fighting white blood cells, in cancer patients after chemotherapy. The standard 6mg do…
Sponsor: Zhejiang Provincial People's Hospital • Aim: Prevention
Last updated Sep 20, 2026 00:00 UTC